<qa>  What is the PHASE III STUDY OF TIVOZANIA PHASE III STUDY OF TIVOZANIB AND ERLOTINIB AS INITIAL TREATMENT FOR METASTATIC NON-SMALL CELL LUNG CANCER ASSIGNED BY VERISTRAT SERUM PROTEOMIC EVALUATION: 